3.97
price up icon2.06%   0.08
after-market Handel nachbörslich: 4.05 0.08 +2.02%
loading
Schlusskurs vom Vortag:
$3.89
Offen:
$3.88
24-Stunden-Volumen:
47,205
Relative Volume:
1.16
Marktkapitalisierung:
$32.86M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-30.16M
KGV:
-8.6304
EPS:
-0.46
Netto-Cashflow:
$-39.49M
1W Leistung:
+0.25%
1M Leistung:
+22.93%
6M Leistung:
+1,176%
1J Leistung:
+922.93%
1-Tages-Spanne:
Value
$3.76
$4.22
1-Wochen-Bereich:
Value
$3.76
$4.28
52-Wochen-Spanne:
Value
$0.27
$4.28

Dare Bioscience Inc Stock (DARE) Company Profile

Name
Firmenname
Dare Bioscience Inc
Name
Telefon
858-926-7655
Name
Adresse
3655 NOBEL DRIVE, SAN DIEGO, CA
Name
Mitarbeiter
26
Name
Twitter
@DareBioscience
Name
Nächster Verdiensttermin
2024-11-07
Name
Neueste SEC-Einreichungen
Name
DARE's Discussions on Twitter

Dare Bioscience Inc Aktie (DARE) Neueste Nachrichten

pulisher
Oct 30, 2024

Dare BioscienceCatering To Women - RTTNews

Oct 30, 2024
pulisher
Oct 30, 2024

Is Bavarian Nordic (BVNRY) Stock Outpacing Its Medical Peers This Year? - Yahoo Finance

Oct 30, 2024
pulisher
Oct 28, 2024

Will It Be A December To Remember For Daré Bioscience? - RTTNews

Oct 28, 2024
pulisher
Oct 27, 2024

Daré Bioscience (NASDAQ:DARE) Publishes Corporate Presentation - Defense World

Oct 27, 2024
pulisher
Oct 25, 2024

Daré Bioscience Enhances Investor Engagement with New Presentation - TipRanks

Oct 25, 2024
pulisher
Oct 25, 2024

Daré Bioscience enters into $15M stock purchase agreement - MSN

Oct 25, 2024
pulisher
Oct 24, 2024

Dare Bioscience shares retain Buy rating on funding reward By Investing.com - Investing.com Canada

Oct 24, 2024
pulisher
Oct 23, 2024

Dare Bioscience awarded $10M for HPV treatment development - Investing.com India

Oct 23, 2024
pulisher
Oct 23, 2024

Dare Bioscience awarded $10M for HPV treatment development By Investing.com - Investing.com South Africa

Oct 23, 2024
pulisher
Oct 23, 2024

Daré Bioscience Selected to Receive $10 Million Award from ARPA-H’s Sprint for Women’s Health - The Bakersfield Californian

Oct 23, 2024
pulisher
Oct 23, 2024

Daré Bioscience Enters Purchase Agreement with Lincoln Park Capital Fund - Defense World

Oct 23, 2024
pulisher
Oct 21, 2024

Dare Bioscience secures $15 million funding agreement By Investing.com - Investing.com Australia

Oct 21, 2024
pulisher
Oct 21, 2024

Dare Bioscience secures $15 million funding agreement - Investing.com

Oct 21, 2024
pulisher
Oct 21, 2024

Daré Bioscience Announces Common Stock Purchase Agreement - GlobeNewswire

Oct 21, 2024
pulisher
Oct 21, 2024

Daré Bioscience Announces Common Stock Purchase Agreement for up to $15 Million with Lincoln Park Capital Fund, LLC - StockTitan

Oct 21, 2024
pulisher
Oct 04, 2024

Brookline Capital Downgrades Daré Bioscience (DARE) - MSN

Oct 04, 2024
pulisher
Sep 26, 2024

Bill Gates helped fund birth control microchip but didn't invent it | Fact check - USA TODAY

Sep 26, 2024
pulisher
Sep 24, 2024

Dye & Durham Limited - Baystreet.ca

Sep 24, 2024
pulisher
Sep 23, 2024

DADA’s 2023 Market Dance: Down -64.46% – Time to Invest? - The InvestChronicle

Sep 23, 2024
pulisher
Sep 22, 2024

Barrow Hanley Mewhinney & Strauss LLC Raises Stake in Darling Ingredients Inc. (NYSE:DAR) - Defense World

Sep 22, 2024
pulisher
Sep 22, 2024

Darling Ingredients Inc. (NYSE:DAR) Shares Sold by Meiji Yasuda Asset Management Co Ltd. - Defense World

Sep 22, 2024
pulisher
Sep 21, 2024

MDA Space shares target raised on Telesat Lightspeed deals By Investing.com - Investing.com Australia

Sep 21, 2024
pulisher
Sep 19, 2024

The Dare Announce 2024 Australian Headlining Shows - Music Feeds

Sep 19, 2024
pulisher
Sep 18, 2024

The Dare Shares Inaugural Australian Tour Dates - The Music

Sep 18, 2024
pulisher
Sep 18, 2024

ADMA Biologics stock soars to all-time high of $19.36 - Investing.com

Sep 18, 2024
pulisher
Sep 16, 2024

The massive, untapped opportunity in women’s health - BioWorld Online

Sep 16, 2024
pulisher
Sep 14, 2024

Daré Bioscience (NASDAQ:DARE) Share Price Crosses Below Two Hundred Day Moving Average of $4.51 - Defense World

Sep 14, 2024
pulisher
Sep 06, 2024

Daré Bioscience (NASDAQ:DARE) Stock Price Passes Below Two Hundred Day Moving Average of $4.59 - Defense World

Sep 06, 2024
pulisher
Sep 02, 2024

Its Stock Has Paid Off Big Time For Dare Bioscience Inc - SETE News

Sep 02, 2024
pulisher
Aug 26, 2024

Daré Bioscience Announces Publication in The Journal of - GlobeNewswire

Aug 26, 2024
pulisher
Aug 26, 2024

Sildenafil cream shows promise for FSAD without common side effects - Investing.com

Aug 26, 2024
pulisher
Aug 26, 2024

Daré Bioscience Announces Publication in The Journal of Sexual Medicine of Positive Safety Findings from the Phase 2b RESPOND Clinical Study of Sildenafil Cream, 3.6% - StockTitan

Aug 26, 2024
pulisher
Aug 24, 2024

Daré Bioscience (NASDAQ:DARE) Shares Pass Below Two Hundred Day Moving Average of $4.62 - Defense World

Aug 24, 2024
pulisher
Aug 17, 2024

Daré Bioscience, Inc. (NASDAQ:DARE) to Post FY2024 Earnings of ($0.33) Per Share, Brookline Capital Management Forecasts - Defense World

Aug 17, 2024
pulisher
Aug 16, 2024

HC Wainwright Comments on Daré Bioscience, Inc.’s Q3 2024 Earnings (NASDAQ:DARE) - Defense World

Aug 16, 2024
pulisher
Aug 16, 2024

Maxim Group Reiterates “Hold” Rating for Daré Bioscience (NASDAQ:DARE) - Defense World

Aug 16, 2024
pulisher
Aug 14, 2024

Sildenafil Cream study suggests simplified patient reporting - Investing.com

Aug 14, 2024
pulisher
Aug 13, 2024

Sildenafil Cream study suggests simplified patient reporting By Investing.com - Investing.com Canada

Aug 13, 2024
pulisher
Aug 13, 2024

Dare Bioscience Inc (DARE) Q2 2024 Earnings Call Transcript High - GuruFocus.com

Aug 13, 2024
pulisher
Aug 13, 2024

Daré Bioscience, Inc. (NASDAQ:DARE) Q2 2024 Earnings Call Transcript - Insider Monkey

Aug 13, 2024
pulisher
Aug 13, 2024

Daré Bioscience Announces Publication in The Journal of Sexual Medicine of Positive Findings from the Phase 2b RESPOND Clinical Study of Sildenafil Cream, 3.6% - StockTitan

Aug 13, 2024
pulisher
Aug 13, 2024

Earnings call: Daré Bioscience reports progress in women's health treatments - Investing.com

Aug 13, 2024
pulisher
Aug 13, 2024

DARE Stock Earnings: Dare Bioscience Beats Revenue for Q2 2024 - InvestorPlace

Aug 13, 2024
pulisher
Aug 12, 2024

Daré Bioscience, Inc. (DARE) Q2 2024 Earnings Call Transcript - Seeking Alpha

Aug 12, 2024
pulisher
Aug 12, 2024

Dare Bioscience, Inc. (DARE) Q2 Earnings Top Estimates - MSN

Aug 12, 2024
pulisher
Aug 12, 2024

Daré Bioscience Reports Second Quarter 2024 Financial Results and Provides Company Update - GlobeNewswire

Aug 12, 2024
pulisher
Aug 12, 2024

Financial Contrast: Daré Bioscience (NASDAQ:DARE) vs. Newron Pharmaceuticals (OTCMKTS:NWPHF) - Defense World

Aug 12, 2024
pulisher
Aug 10, 2024

Daré Bioscience (DARE) Set to Announce Earnings on Monday - Defense World

Aug 10, 2024
pulisher
Aug 05, 2024

Daré Bioscience to Host Second Quarter 2024 Financial - GlobeNewswire

Aug 05, 2024
pulisher
Aug 05, 2024

Daré Bioscience to Host Second Quarter 2024 Financial Results and Company Update Conference Call and Webcast on August 12, 2024 - StockTitan

Aug 05, 2024
pulisher
Aug 03, 2024

Daré Bioscience (NASDAQ:DARE) Shares Cross Below 200-Day Moving Average of $4.67 - Defense World

Aug 03, 2024

Finanzdaten der Dare Bioscience Inc-Aktie (DARE)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$77.28
price up icon 2.02%
$20.39
price up icon 2.15%
$382.77
price up icon 1.58%
$53.29
price down icon 0.47%
$208.03
price up icon 0.38%
$110.97
price up icon 1.84%
Kapitalisierung:     |  Volumen (24h):